ATE432708T1 - Therapeutische anwendungen von beta-casein a2 und nahrungsergänzung mit beta-casein a2 - Google Patents

Therapeutische anwendungen von beta-casein a2 und nahrungsergänzung mit beta-casein a2

Info

Publication number: ATE432708T1
Authority: AT; Austria
Prior art keywords: casein; beta; sup; cholesterol; density lipoprotein
Prior art date: 2002-10-04

Application number

AT03770160T

Other languages

English (en)

Inventor

Julie Hazel Campbell

Kristy Ann Tailford

Ulrike Hf Mclachlan

Corran Norman Stuart Mclachlan

Original Assignee

A2 Corp Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-04

Filing date

2003-10-03

Publication date

2009-06-15

2003-10-03 Application filed by A2 Corp Ltd filed Critical A2 Corp Ltd

2009-06-15 Application granted granted Critical

2009-06-15 Publication of ATE432708T1 publication Critical patent/ATE432708T1/de

Links

102000011632 Caseins Human genes 0.000 title abstract 7
108010076119 Caseins Proteins 0.000 title abstract 7
235000021247 β-casein Nutrition 0.000 title abstract 7
235000015872 dietary supplement Nutrition 0.000 title abstract 2
230000001225 therapeutic effect Effects 0.000 title 1
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 10
235000012000 cholesterol Nutrition 0.000 abstract 5
108010007622 LDL Lipoproteins Proteins 0.000 abstract 4
102000007330 LDL Lipoproteins Human genes 0.000 abstract 4
108010010234 HDL Lipoproteins Proteins 0.000 abstract 2
102000015779 HDL Lipoproteins Human genes 0.000 abstract 2
108010062497 VLDL Lipoproteins Proteins 0.000 abstract 2
101710095342 Apolipoprotein B Proteins 0.000 abstract 1
102100040202 Apolipoprotein B-100 Human genes 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
235000013305 food Nutrition 0.000 abstract 1
230000037406 food intake Effects 0.000 abstract 1
210000002966 serum Anatomy 0.000 abstract 1
150000003626 triacylglycerols Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
General Chemical & Material Sciences (AREA)
Food Science & Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
Marine Sciences & Fisheries (AREA)
Polymers & Plastics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Mycology (AREA)
Nutrition Science (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT03770160T 2002-10-04 2003-10-03 Therapeutische anwendungen von beta-casein a2 und nahrungsergänzung mit beta-casein a2 ATE432708T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
NZ52195502		2002-10-04
PCT/NZ2003/000222 WO2004030690A1 (en)	2002-10-04	2003-10-03	THERAPEUTIC USES OF β-CASEIN A2 AND DIETARY SUPPLEMENT CONTAINING β-CASEIN A2

Publications (1)

Publication Number	Publication Date
ATE432708T1 true ATE432708T1 (de)	2009-06-15

Family

ID=32065083

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03770160T ATE432708T1 (de)	2002-10-04	2003-10-03	Therapeutische anwendungen von beta-casein a2 und nahrungsergänzung mit beta-casein a2

Country Status (14)

Country	Link
US (1)	US20060280802A1 (de)
EP (1)	EP1562629B1 (de)
JP (1)	JP4870355B2 (de)
KR (1)	KR101065099B1 (de)
CN (1)	CN100377740C (de)
AT (1)	ATE432708T1 (de)
AU (1)	AU2003278625A1 (de)
CA (1)	CA2500530C (de)
DE (1)	DE60327880D1 (de)
DK (1)	DK1562629T3 (de)
ES (1)	ES2329031T3 (de)
HK (1)	HK1082910A1 (de)
NZ (1)	NZ538904A (de)
WO (1)	WO2004030690A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2004004450A1 (en) *	2002-07-03	2004-01-15	A2 Corporation Limited	Method for altering fatty acid composition of milk
CN101410131B (zh) *	2006-06-09	2012-09-12	森永乳业株式会社	脂质代谢改善剂
ES2400631T3 (es) *	2008-12-09	2013-04-11	Unilever Nv	Dulces helados aireados y procedimientos de producción de los mismos
SG10201709509RA (en)	2013-05-31	2017-12-28	A2 Milk Co Ltd	Beta-Casein A2 And Prevention Of Inflammation Of The Bowel
JP6436592B2 (ja) *	2013-07-12	2018-12-12	ズィ・エイツー・ミルク・カンパニー・リミテッド	ベータカゼインａ２およびラクトース不耐性の症状の低減または予防
WO2015026245A1 (en) *	2013-08-23	2015-02-26	The A2 Milk Company Limited	Beta-casein a2 and blood glucose levels
CA2826315A1 (en)	2013-09-06	2015-03-06	Mattawa Industrial Services Inc.	Elevation conveyance system and method
US10702580B2 (en) *	2015-05-22	2020-07-07	The A2 Milk Company Limited	Beta-casein A2 and antioxidant capacity
CA3036494C (en) *	2016-09-30	2022-10-18	The A2 Milk Company Limited	Beta-caseins and gut microbiota

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH06165655A (ja) *	1992-06-26	1994-06-14	Meiji Milk Prod Co Ltd	コレステロール低減用組成物
AU691362B2 (en) *	1994-11-04	1998-05-14	New Zealand Dairy Board	Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected
US6570060B2 (en) *	1995-05-16	2003-05-27	Mclachlan Corran Norman Stuart	Milk lacking β-casein A1
AU723396B2 (en) *	1995-05-16	2000-08-24	Corran Norman Stuart Mclachlan	Food product and process
AU771754B2 (en) *	1999-06-29	2004-04-01	New Zealand Milk Institute Limited, The	Prophylactic dietary supplement based on milk

2003
- 2003-09-29 US US10/530,209 patent/US20060280802A1/en not_active Abandoned
- 2003-10-03 CN CNB2003801049265A patent/CN100377740C/zh not_active Expired - Lifetime
- 2003-10-03 DE DE60327880T patent/DE60327880D1/de not_active Expired - Lifetime
- 2003-10-03 NZ NZ538904A patent/NZ538904A/en not_active IP Right Cessation
- 2003-10-03 AU AU2003278625A patent/AU2003278625A1/en not_active Abandoned
- 2003-10-03 WO PCT/NZ2003/000222 patent/WO2004030690A1/en active Application Filing
- 2003-10-03 KR KR1020057005882A patent/KR101065099B1/ko active IP Right Grant
- 2003-10-03 ES ES03770160T patent/ES2329031T3/es not_active Expired - Lifetime
- 2003-10-03 DK DK03770160T patent/DK1562629T3/da active
- 2003-10-03 JP JP2004541349A patent/JP4870355B2/ja not_active Expired - Lifetime
- 2003-10-03 CA CA2500530A patent/CA2500530C/en not_active Expired - Lifetime
- 2003-10-03 AT AT03770160T patent/ATE432708T1/de not_active IP Right Cessation
- 2003-10-03 EP EP03770160A patent/EP1562629B1/de not_active Expired - Lifetime
2006
- 2006-03-02 HK HK06102730A patent/HK1082910A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
WO2004030690A1 (en)	2004-04-15
CN100377740C (zh)	2008-04-02
CN1720062A (zh)	2006-01-11
KR101065099B1 (ko)	2011-09-16
EP1562629A4 (de)	2007-08-29
ES2329031T3 (es)	2009-11-20
HK1082910A1 (en)	2006-06-23
JP2006501299A (ja)	2006-01-12
CA2500530C (en)	2013-01-08
AU2003278625A1 (en)	2004-04-23
US20060280802A1 (en)	2006-12-14
CA2500530A1 (en)	2004-04-15
JP4870355B2 (ja)	2012-02-08
EP1562629A1 (de)	2005-08-17
NZ538904A (en)	2009-04-30
DK1562629T3 (da)	2009-10-12
KR20050087785A (ko)	2005-08-31
DE60327880D1 (de)	2009-07-16
EP1562629B1 (de)	2009-06-03

Legal Events

Date	Code	Title	Description
2009-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
HK1082910A1 (en)	2006-06-23	Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2
UA88633C2 (ru)	2009-11-10	Структурированная композиция на основе липидов, способ ее изготовления и способ снижения атерогенного риска человека
Cordova et al.	2005	The cardiovascular protective effect of red wine
NO990559D0 (no)	1999-02-05	Stanolsammensetninger og anvendelse derav
CO5550402A2 (es)	2005-08-31	Composicion para disminuir el colesterol en la sangre
MY121405A (en)	2006-01-28	4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines
BR9707713A (pt)	2000-01-04	Composição e sua utilização como umm suplemento alimentar ou para reduzir o nìvel plasmático de lipìdios.
WO2004016101A3 (en)	2004-04-29	Compositions comprising dietary fat complexer and methods for their use
BR0209856A (pt)	2004-06-15	Método para a destruição de oocistos
WO2001032160A3 (en)	2002-03-21	Modification of cholesterol concentrations with citrus phytochemicals
AR025320A1 (es)	2002-11-20	Composicion liquida para mejorar el pan
WO2004089992A8 (ja)	2005-01-20	改質アラビアガムおよびその用途
Bellido et al.	2006	The Mediterranean and CHO diets decrease VCAM-1 and E-selectin expression induced by modified low-density lipoprotein in HUVECs
Cater	2000	Plant stanol ester: review of cholesterol‐lowering efficacy and implications for coronary heart disease risk reduction
IL160533A0 (en)	2004-07-25	Methods of screening molecules that are used to prevent cardiovascular diseases
DK1660097T3 (da)	2009-03-30	Fysiologisk aktiv sammensætning baseret på phosphatidylserin
DK1611794T3 (da)	2012-07-02	Margarinelignende fødevaresammensætning med reduceret fedtindhold
ATE290795T1 (de)	2005-04-15	Medizinische zusammensetzung zur behandlung und/oder zur verhinderung von unterernährung
BRPI0414628A (pt)	2006-11-07	incorporação de fitoesteróis em aromatizantes
Meletis	1998	Dietary and lifestyle interventions for a healthy heart
DE69908259D1 (de)	2003-07-03	Neues anethanol enthaltend klares gegebenfalls alkoholisches getränk und trübes verdünntes getränk hergestellt durch verdünnung
Braith	2003	Does resistance exercise training reduce the risk of cardiovascular disease?
Slaiby	2002	Effect of chronic and non-chronic moderate wine consumption upon rat lipoprotein profile in the blood.(c2002)
WO1991015204A3 (en)	1991-11-28	Method and agents for the selective reduction of lp(a)
Preboth	2001	Cardiovascular benefits of soy protein